MC 2214 D-Ribose, [1-14C]- |
|
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
Ethanol:water (3:7) solution, 100 µCi/ml | |
> 50 mCi(1.85 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
NextGen V-Vial | 250 µCi (9.25 MBq) $5420 |
M.W. 150.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1504 D-Ribose, [1-3H]- Click here for Typical Certificate of Analysis |
|
Delivered ≥ 96% pure with dated HPLC radiochromatogram | |
Ethanol:water (9:1) solution, 1 mCi/ml | |
> 10 Ci(370 GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
NextGen V-Vial | 1 mCi (37 MBq) $2590 |
M.W. 150.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1504L D-Ribose, [1-3H]- |
|
Delivered ≥ 96% pure with dated HPLC radiochromatogram | |
Ethanol:water (9:1) solution, 1 mCi/ml | |
4-10 Ci(148-370 GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
NextGen V-Vial | 1 mCi (37 MBq) $2590 |
M.W. 150.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 2021 L-Ribose, [1-14C]- |
|
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
Ethanol:water (3:7) solution, 100 µCi/ml | |
> 50 mCi(1.85 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
NextGen V-Vial - shipped on dry ice | |
M.W. 150.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 541 D-Ribose, [5-3H]- (Discontinued) |
MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
Ethanol:water (1:1) solution, 1 mCi/ml |
> 10 Ci(370 GBq)/mmol |
NextGen V-Vial |
M.W. 150.1 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |